InvestorsHub Logo

westeffer

02/23/17 5:04 AM

#46332 RE: The Rainmaker #46330

I agree Rain on NMUS, been loading up as much as I could afford and just to be safe took down an equal load of IMLFF.

IMLFF uses an organic growth method to produce the 90 elusive and hard to reproduce CBD's and NMUS uses a synthetic approach to do the same. It appears NMUS could enter clinical trials as early as this year and IMLFF in 2018 from what I can see.

I think both are much better bargains than OWCP and have huge future potential. A key Lilly VP just joined the IMLFF Board.